Tevogen Bio Holdings Inc. (TVGN)

Tevogen Bio Holdings Market Cap

Tevogen Bio Holdings has a market cap or net worth of $136.25 million as of May 17, 2024. Its market cap has decreased by -23.07% in one year.

• Market Cap: 136.25M
• Enterprise Value: 230.62M
• 1-Year Change: -23.07%
• Ranking: #3867
• Category: Micro-Cap
• Stock Price: $0.82

Market Cap Chart

Since November 4, 2021, Tevogen Bio Holdings's market cap has decreased from $421.50M to $136.25M, a decrease of -67.67%. That is a compound annual growth rate of -35.99%.

Market Cap History

Date	Market Cap	% Change
May 16, 2024	146.50M	-8.27%
May 15, 2024	159.70M	5.48%
May 14, 2024	151.40M	-8.02%
May 13, 2024	164.60M	1.54%
May 10, 2024	162.10M	-0.61%
May 9, 2024	163.10M	-0.91%
May 8, 2024	164.60M	0.92%
May 7, 2024	163.10M	3.23%
May 6, 2024	158.00M	-1.06%
May 3, 2024	159.70M	-1.60%
May 2, 2024	162.30M	1.63%
May 1, 2024	159.70M	-2.98%
Apr 30, 2024	164.60M	-
Apr 29, 2024	164.60M	7.44%
Apr 26, 2024	153.20M	17.57%
Apr 25, 2024	130.30M	-43.32%
Apr 24, 2024	229.90M	-9.09%
Apr 23, 2024	252.90M	-1.17%
Apr 22, 2024	255.90M	-9.74%
Apr 19, 2024	283.50M	-12.74%
Apr 18, 2024	324.90M	-7.22%
Apr 17, 2024	350.20M	-3.18%
Apr 16, 2024	361.70M	0.44%
Apr 15, 2024	360.10M	-4.10%
Apr 12, 2024	375.50M	-0.79%

View and export this data all the way back to 2021. Sign Up Today.

Related Stocks

Company	Market Cap
ProQR Therapeutics	160.42M
Cardiff Oncology	160.11M
Accuray	158.79M
Repare Therapeutics	156.62M
Vaxart	152.91M
Renovaro Biosciences	149.41M
Harvard Bioscience	148.96M
Cardiol Therapeutics	148.83M